IBSA USA
Meghan Hunter has accumulated substantial sales experience across various industries. Currently serving as an Endocrinology/Pain Sales Specialist at IBSA USA since March 2022, Meghan previously worked as a Home Care and Vascular Sales Representative at Essity from October 2020 to March 2022. Prior roles include serving as a Small Business Sales Consultant at Paychex for one year and holding multiple positions at Ellis Coffee Company, including Regional and District Sales Manager from January 2016 to October 2019. Earlier experience includes working as a Retail Sales Representative and a Retail Development Intern at The Hershey Company between 2014 and 2016. Meghan Hunter holds a Bachelor's degree in Food Marketing from Saint Joseph's University, earned in 2015.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.